INTRODUCTION
Cytomegalovirus (CMV) is a species-specific p-herpesvirus that is present in the majority of the population (60%-90%)'). Active CMV infection often develops in immunocompromised hosts, such as human immunodeficiency virus infection, receiving chemotherapy for malignant tumors, and immunosuppressive agents for organ transplantation or autoimmune diseases.
Recently, several reports suggest that steroid -refractory ulcerati ve colitis (UC) correlates with CMV infection 2-4). CMV infection can aggravate UC on a basis of immunosup pressive state, a nd cause fata l organ damage. However, there has been no previous report describing a case with CMV pneum on ia developed in a patient with Uc. In thi s report, we present a case of late-onset UC com plicated with CMV pneum oni a, revealed by autopsy.
CASE REPORT
A 77 -yea r-old woman had experienced lower abd omina l pain and diarrhea since January, 2003. In February, she had a di agnosis of UC and received prednisolone for three months, but the colitis was refra ctory to the therapy. She was referred t o our hosp ita l in May. On adm ission, she suffered from lower abdomina l pain. She had bloody stool or di arrhea 5 times a day. On physical examinati on, her body temperature was 37.0°C, her heart bea t was 80/ min , and blood pressure was 110/ 80 mmHg. Her bowel sounds were wea k. She had tenderness in the left lower quadrant of abdomen. Hematological examination showed anemia, red blood cell count of 311 X 10 4 / J..lI and hemoglobin of 9.0 g/ dl , and norm a l white blood cell count of 5, 100 / J..l1. The level of C-reactive protein was 1.3 mg/ dl, and er ythrocyte sedimenta tion rate was 52 mm in 1 hour. T he levels of total protein and serum albumin were 5.6 g/ dl , 2.4 g/ dl , respectively. Di sease activity of UC was moderate according to the Truelove and W itt's criteri a, whi ch classified by the ex tent of bl oody stool, feve r, pulsation, a nemia, repeat of defeca tion, and a high erythrocyte sedim entation rate 5 ) Sigmoidscopy showed abrupt mucosa, pseudopo lyposis, and consecuti ve multiple deep ulcers from the rectum to sigmoid colon ( Fig. 1 ). Biopsied specimen F ig. 1. Sigm oidscopy showed co nsecut ive abru pt mucosa, spontaneo us bl eeding and mul t iple deep ulcer s. showed typical histological findings of DC. She received methylprednisolone in a dose of 500 mg for 3 days, followed by high doses of prednisolone (60 mg/day) ( Fig.  2 ). Also, she was treated with leukocytapheresis once a week for 10 times. Her symptoms improved slightly, but did not disappear. In June, CMV -pp65 antigenemia test revealed positive, which suggested systemic or colonic CMV infection. She received ganciclovir (GCV) in a dose of 5 mg/kg for 11 days, but GCV was discontinued because of thrombocytopenia and liver dysfunction. Then, she was referred to surgery because the colitis was refractory to the therapy. In July, she suddenly experienced high fever and dyspnea. Chest X -ray and CT showed groundglass appearance of both lungs. In spite of intensive care, she suffered from acute respiratory distress syndrome and bilateral pneumothorax. She died of a respiratory failure and severe anemia. Autopsy findings showed consecutive deep ulcers from rectum to transverse colon compatible with DC, and severe CMV infection in capillary endothelium of proper muscle layer (Fig. 3A) . Both lungs showed diffuse alveolar damage (DAD) with organized hyaline membrane in alveolar walls, including numerous CMV -infected cells (Fig. 3B) . Cause of death was respiratory failure due to organized DAD. Massive bleeding from colon ulcers might also contribute to the deterioration of general condition.
DISCUSSION
CMV is a common infection, and it appears to be an important contributing factor to steroid-refractory disease in patients with DC2-4). As in this case, CMV infection may be systemic, and it is a potentially fatal complication in patients with A B Fig. 3 . Histo logica l fin dings of the transverse colon and the lung . A. N um erous CMV infected cell s we re observed espec ia ll y in ca pillary end othe lium, show ing CMV coli t is based on ulcerat ive coliti s. Arrows indi cate the in clusion bodi es ( x 400). B. Diffuse a lveo lar damage was shown with orga ni zed hya line membrane in a lveo la r wa ll s (l e ft , x 150) . Nu merou s CMV -infected cell s on the a lveo la r wa ll s a re indi cated by a rrows (rig ht, X 400).
inflammatory bowel disease, especiall y in those treated with multiple immunomodulators. Outcome of CMV infections in patients with infl amm atory bowel disease (IBD) has been reported mortality rate of 30%4). Prompt diag nosis of CMV colitis by CMV pp65 test, anti -CMV IgM, PCR, and hi stological a na lysis a llows prompt treatment with GCV, which provides clinical response in steroid-refract ory UO·"·6) However, establishing a di agnosis of acti ve CMV infection is challenging in those patients because CMV co li tis is often clinicall y indistinguishable from an episode of acute co litis. In fact, GCV was admini stered in this patient before establishing a diagnosis of CMV colitis or pneumonia because positive CMV pp65 antigenemia test suggested a systemic CMV infection. However, the antiviral therapy was insufficient because of the GCV· side effects. To the best of our knowledge, there has been no previous report describing a case with CMV pneumonia developed in a patient with Uc. Two cases with CMV pneumonia developed in patients with Crohn's disease have been reported 3 • 7 ) . Their ages were 19 and 51-years old. They were treated with steroid, 6-mercaptopurine, ciclosporin, or 5-aminosalicylic acid before the onset of CMV pneumonia. Both patients received GCV for the treatment of CMV pneumonia; one of them was discharged and the other died. Although risk factors of CMV infection have not fully been investigated in UC patients, Kishore et at. suggested female gender, pancolitis, or histological activity were the independent risk factors 4 ). CMV colitis is well described in acquired immunodeficiency syndrome patients, in organ transplant patients, in patients receiving immunosuppressants or steroids, in patients with cancer or receiving chemotherapy, and in the elderly, particularly those who suffer from chronic illness 8 ). Onset of UC after the age of 65 is not common, for example, the number of the patients who had a diagnosis of UC at the age of over 60 were 12 of 168 (7.14%) in Japan 9 ). Late-onset UC was shown to be more aggressive, resistant to the conventional therapy, and associated with high rate of complications. Almogy et at. proposed that urgent surgery and hypoalbuminemia were predictors of adverse outcome in the elderly population suffering from late-onset UC and requiring an operation 10 ) . It is difficult to manage elderly patients with severe colitis unresponsive to conventional therapy. Absolute indications for surgery are exsanguinating hemorrhage, perforation, and documented or strongly suspected carcinoma ll ). In this case, surgical treatment was planned without absolute indications for surgery, because her colitis was unresponsive to the conventional therapy. But it was unable because of the onset of CMV pneumonia. Majority of patients with UC does not require surgery, however, this case may propose that elderly patients should be referred to surgery earlier than young patients if the colitis was refractory to the conventional therapy, and that we should be aware of the risks and benefits of operations within different clinical settings. In conclusion, we described a rare case of UC complicated with CMV pneumonia revealed by autopsy. Further studies are needed in elderly patients with steroidrefractory UC to establish new tools for diagnosing CMV colitis at early stage, to evaluate high risk group for CMV infection, and to assess an indication of prophylactic therapy with GCV in such group.
